Views & Analysis

Views & Analysis
a-closer-look-at-cancer

NICE numbers at 20 – a closer look at cancer

There has been continual interest in what the UK’s Health Technology Assessment (HTA) agency, the National Institute for Health and Care Excellence (NICE), has said when it comes to cancer

Views & Analysis
The Japanese healthcare revolution

The Japanese healthcare revolution

Something that always strikes me when visiting Japan is the uber-modern infrastructure and services enjoyed by residents and visitors alike.

Views & Analysis
Industry-Pulse-feature-28_08_2019

Who could replace Sir Andrew Dillon at NICE?

With Sir Andrew Dillon announcing his retirement as chief executive of NICE, pharmaphorum discusses potential replacements for the man who is arguably the most influential figure in health

Views & Analysis
legalisation medical cannabis

Addressing the medical cannabis knowledge gap

The legalisation of medical cannabis in November 2018 was hailed as a landmark victory for the British medical industry, with scientists, researchers and patients alike all welcoming the ch